The most commonly characterized selective Pde2a inhibitor, namely Bay 60–7550, generates antidepressant efficacy in the depression animal model (Masood et al., 2009; Xu et al., 2013; Ding et al., 2014). This evidence concerns the gene PDE2A and depressive symptom measurement.